| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.031 | 0.6 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |